| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | selumetinib:MK-2206 (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.098 | 0.006 |
| mRNA | TAE684 | GDSC1000 | pan-cancer | AAC | -0.17 | 0.006 |
| mRNA | Erlotinib | CCLE | pan-cancer | AAC | -0.13 | 0.006 |
| mRNA | ML203 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.006 |
| mRNA | purmorphamine | CTRPv2 | pan-cancer | AAC | 0.1 | 0.006 |
| mRNA | triptolide | CTRPv2 | pan-cancer | AAC | -0.097 | 0.006 |
| mRNA | Vandetanib | CCLE | pan-cancer | AAC | -0.13 | 0.006 |
| mRNA | dabrafenib | GDSC1000 | pan-cancer | AAC | 0.087 | 0.007 |
| mRNA | tamatinib | CTRPv2 | pan-cancer | AAC | -0.1 | 0.007 |
| mRNA | bafilomycin A1 | CTRPv2 | pan-cancer | AAC | 0.37 | 0.007 |